Mayzent 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FW4GC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,123
Award facts
- Contract value 100% obligated
- $21,122.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,122.61 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 30, 2026, for the supply of Mayzent 1 mg tablets (30-count units). The contract, which carries an ultimate completion date of February 23, 2026, represents a non-set-aside competitive award. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The performance location is identified as Conshohocken, PA, where the company maintains its corporate operations.
This delivery order is executed under AmerSourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031. This primary contract vehicle enables comprehensive pharmaceutical supply support across multiple therapeutic domains for military healthcare programs and federal medical institutions worldwide. The current award for Mayzent, a specialty pharmaceutical used in neurological treatment, exemplifies the company's role in fulfilling critical medication requirements for the Defense Health Agency and other government healthcare systems through the DLA's global pharmaceutical support network.
Quick answers
Who was awarded contract SPE2DR26FW4GC?
SPE2DR26FW4GC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FW4GC worth?
The government has obligated $21,123 on SPE2DR26FW4GC.
Is contract SPE2DR26FW4GC an order under another contract?
Yes. SPE2DR26FW4GC is a delivery order under SPE2DR25D7067, an indefinite delivery contract.
Was contract SPE2DR26FW4GC competed?
The extent of competition for SPE2DR26FW4GC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award